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Introduction

Pathophysiological Processes
Underlying Pathophysiology

Congenital heart defects are the most common type of birth defects and
can range from minor to severe. A severe and rare form of congenital
heart disease is hypoplastic left heart syndrome (HLHS). HLHS consists of
the underdevelopment of the left sided heart structures leading to the
failure of the left ventricle to support the systemic circulation resulting in
single ventricle physiology ( Mussa & Barron, 2016). HLHS can be
dangerous and life threatening if not treated within the first few days of
life ( Mussa & Barron, 2016). The Center of Disease Control and
Prevention estimates that 1,025 babies are born each year in the United
States with hypoplastic left heart syndrome (2019).
The topic of HLHS was chosen because healthcare providers need to
have the knowledge of how to approach care for the HLHS patient
population. As medical and surgical advancements continue an increased
number of patients with HLHS are reaching adulthood. Therefore, to
provide the best outcomes for patients with HLHS it is imperative that
healthcare providers receive appropriate education on the epidemiology,
pathophysiology, physiology, treatment plans, and the surgical and
medical management of this complex patient population.

HLHS occurs during fetal cardiac development.
HLHS has no known cause and is present at birth.
No association with maternal age or parity (Mussa & Barron, 2016).
There are associations with chromosomal abnormalities. (Mussa & Barron, 2016).
“HLHS is slightly more common in males, but there is no ethnic or geographic association” (Benson et al., 2016, p.25).
Evidence is suggesting a genetic component is likely but thought to be complex and multifactorial (Mussa & Barron, 2016).
In HLHS “hypoplasia of the left ventricle (LV) and aorta are cardinal features, but the pathologic definition also includes atresia or stenosis
of both the aortic and mitral valves” (Benson et al., 2016, p.25). Therefore, the left side of the heart can not support the systemic circulation
(Mussa & Barron, 2016).
For survival, the right ventricle must support the systemic circulation through the right to left flow of blood across a patent ductus
arteriosus (PDA) (Mussa & Barron, 2016). Adequate mixing of oxygenated and deoxygenated blood at the atrial level through the atrial
septal defect is also essential for survival (Figure 1) (Hass et al., 2017).
The right ventricle is the systemic pumping chamber and cardiac output is dependent on the patent ductus arteriosus (PDA), which
normally closes a few days after birth and is kept patent by intravenous infusion of prostaglandin E until surgery is performed. (Cheatham
& Deyo, 2016, p.49).
“A widely accepted hypothesis is that HLHS develops as a result of embryonic alterations in blood flow, such as premature narrowing of
the foramen ovale or aortic valve obstruction” (Benson et al., 2016, p.26).
“An alternative hypothesis for HLHS etiology focuses on the summation of the coordinated actions of signaling pathways and gene
regulatory networks that guide the complex process of heart development” (Benson et al., 2016, p.26).
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Figure 1. normal heart (left) and hypoplastic left heart (right).
Retrieved from https ://healthjade.com/hypoplastic left heart syndrome/
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Symptoms are present at birth or shortly after birth.

▪

After confirmation of HLHS diagnosis all treatment options need to be explained to
families to empower them to make an informed decision (Mussa & Barron, 2016).

▪

Treatment options range from surgery to no intervention (comfort care) (Mussa &
Barron, 2016).

▪

Survival rates have increased over time for patients with HLHS due to advancements in
surgical technique, postoperative management, and perfusion strategies (Donnellan &
Justice, 2016).
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Tachypnea
Tachycardia
Weak pulse
Poor feeding
Cyanosis
Lethargy

▪

(Mayo Clinic, 2018).

Postnatally the newborn pulse
oximetry screening can detect low
oxygen levels in the blood, possibly
indicating a sign of critical congenital
heart disease (Centers of Disease
Control and Prevention, 2019).
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Prenatally or postnatally
Prenatal diagnosis can be detected by ultrasound in the second trimester of pregnancy.
If HLHS is suspected by ultrasound a fetal echocardiogram can confirm diagnosis and
show structural abnormalities and how the heart is working (Health Jade, 2018).
A prenatal diagnosis by ultrasound allows for parent preparedness, prognosis, possible
outcomes, and planning of postnatal management (Mussa & Barron, 2016).
Prenatal diagnosis allows for better hemodynamic stability when compared with a
postnatal diagnosis which improves neurodevelopmental outcomes (Mussa & Barron,
2016).
Postnatal diagnosis is also confirmed by an echocardiogram.

Signs and Symptoms

•

•

HLHS is a single-ventricle physiology and persists throughout a patient's life (Donnellan & Justice, 2016).
Complex and fragile patient population.
HLHS is a fatal condition if left untreated.
Without treatment HLHS would be responsible for 25-40% of all neonatal cardiac deaths (Mussa &Barron, 2016).
Prevention of HLHS not possible.
There is an increased risk of having a second child with congenital heart disease if the first child has HLHS (Health Jade, 2018).
Prior to the 1980s HLHS was a universally lethal condition until 1982, when surgical management became available (Mussa &
Barron, 2016).
However, surgical management is not curative because the heart can never be “normal” (Mussa & Barron, 2016).
The surgical management of HLHS requires “a series of three staged operations that focuses on utilizing the right ventricle to
support the systemic circulation” (Mussa & Barron, 2016, p.75).
Children born with HLHS after their first stage operation remain medically fragile until they have undergone the second stage
operation (Nieves et. al., 2017).
Life expectancy and exercise capacity is decreased (Hass et al., 2017).

Diagnosis
•
•
•

Implications for Nursing Care
Important to avoid early delivery when possible
because early term of 37 to 38 weeks’ gestation is
associated with worse outcomes after cardiac
neonatal surgery (Donnellan & Justice, 2016).
Variation exists in both surgical and medical
management in infants with HLHS (Donnellan &
Justice, 2016).
Postoperatively key nursing interventions include
pain management and avoiding hyperventilation,
which increases pulmonary blood flow and
decreases systemic output, monitoring vital signs
closely, temperature regulation, and identifying
presence of acidosis (Draben, 2018).
Fragile and complex patient population.
Growth and nutrition must be continually
assessed.
Before discharge from the hospital and throughout
continued follow-up appointments family
education on a variety of topics is imperative due
to the complexity of HLHS.
Teaching the family to monitor their infant for
signs and symptoms of deterioration and notify the
healthcare team with any concerns is crucial for
early detection of problems that may warrant
treatment. (Nieves et al., 2017).
Consider the stress burden to the family and offer
resources such as counseling.
Heart transplantation is not primary treatment
because neonatal heart donors are rare and to wait
for a suitable organ could lead to death. The series
of three staged operations is preferred primary
treatment (Mussa & Barron, 2016).
Heart transplantation is a secondary option in
children or adults who run into heart failure later
in life (Mussa & Barron, 2016).
HLHS requires lifelong routine follow-up visits
with a cardiologist to monitor patient’s progress
(Centers of Disease Control and Prevention, 2019).
As medical and surgical advancements continue an
increased number of patients with HLHS are
reaching adulthood.

Conclusion

Figure 2. Displays the various surgical pathway
for HLHS. This Photo by Unknown Author is
licensed under CC BY-NC

HLHS is life threatening if not treated within the first
few days of life. HLHS is a rare and severe form of
congenital heart disease and requires a cohesive
multidisciplinary team to bring forth best outcomes. The
ongoing research in genetics brings hope to identifying a
cause for HLHS. As medical and surgical advancements
continue an increased number of patients with HLHS are
reaching adulthood which creates a unique and
challenging set of problems (Mussa & Barron, 2016).
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